I

Incyte

Biopharmaceutical company pursuing drug discovery.

Global Forecasting and Market Research Director

Corporate StrategyUpdated on Nov 10
Full-timeWilmington, DE, USANo salary listedIn-person

About the Job

Requirements

  • A bachelor's degree and at least 8 years of experience in biopharmaceutical forecasting, commercial insights, strategy, or related analytics, including oncology or hematology experience.
  • Hands-on experience building patient-based forecast models, including patient flow, line-of-therapy, and treatment-sequencing logic.
  • Deep knowledge of forecasting methodology, epidemiology, prescription and claims data, and other secondary sources, with sound judgment on when to use each.
  • Ability to communicate complex information clearly, articulate risks and recommendations, and influence strategic decisions.
  • Experience commissioning and interpreting primary market research and translating findings into forecast assumptions and scenarios.
  • Strong Excel modeling skills and comfort with emerging AI tools.
  • Ability to work independently in a fast-moving, global environment.

Responsibilities

  • Develop global, patient-based commercial forecasts by region for early- and late-stage oncology assets.
  • Build and maintain transparent models integrating epidemiology, patient flow and treatment sequencing, the competitive landscape, pricing and access, and analogs.
  • Lead scenario and sensitivity analysis to support portfolio prioritization, resource allocation, and long-range planning.
  • Present forecasts, risks, and recommendations to senior leaders to inform portfolio decisions.
  • Partner with cross-functional teams to align on assumptions and scenarios.
  • Partner with regional forecasting teams to align global and local views and resolve differences.
  • Provide assumptions and insights for Business Development assessments.
  • Select epidemiology, claims, and syndicated data sources, and document the rationale for key assumptions.
  • Design and oversee primary market research with physician, payer, and patient audiences using external vendors, and translate findings into forecast inputs and strategic recommendations.
  • Monitor the competitive and clinical landscape and flag changes that affect forecast assumptions.
  • Use forecasting methodologies and vendor partnerships to deliver research and analysis across geographies and programs.
  • Identify and pilot AI and automation approaches to improve forecast speed, consistency, and insight quality, and help build practical tools for the team.
  • Contribute to forecasting standards, templates, and governance across the function.
  • Manage contracts and subscriptions to maintain breadth of insights resources.

Desired Qualifications

  • Significant experience with both solid tumor and hematology forecasting and/or launch forecasting.
  • Global or multi-region forecasting experience, or consulting or vendor-side work.
  • Practical experience applying AI or automation to forecasting or analytics, or building tools.
  • Experience supporting Business Development evaluations or due diligence.
  • An advanced degree (MBA, MS, PharmD, or PhD).

About the Company

Incyte

Biopharmaceutical company pursuing drug discovery.

Incyte develops and sells medicines by discovering and developing new drugs, focusing on diseases in inflammation, autoimmunity, and blood cancers. Its core product, Jakafi (ruxolitinib), is a JAK1/2 inhibitor approved to treat a rare blood cancer and works by blocking JAK enzymes to reduce abnormal blood cell growth. The company also expands its pipeline through research collaborations, partnerships, and acquisitions, such as the 2024 purchase of Escient Pharmaceuticals to strengthen its inflammation and autoimmune portfolio. Unlike some competitors that rely mainly on internal programs, Incyte combines in-house discovery with external collaborations and strategic deals to grow its drug candidates from early research to approved therapies. The goal is to deliver medicines that help patients with serious diseases by building a diverse, clinically validated portfolio of treatments through internal efforts and partnerships.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Wilmington, DE
Founded
1991

Recently Posted Jobs

Explore more opportunities at Incyte

See more jobs